Despite a generally gloomy outlook Stryker financials and predictions for 2012 look strong from preliminary report.
Financial Results
Growth From Outside Eu and US for Biomet
Biomet Inc’s second quarter preliminary net sales reports have been published and show a continuation of the tendency for highest growth levels to be coming from ex-USA and ex-Eu sources.
Carl Zeiss Meditec Closes Financial Year on a High and Pursues Growth Course
Carl Zeiss Meditec bucks the trend with growth in all business areas and increased profitability.
International Sales Growth Means Exactech Q3 Revenue Up 13%
US sales down, International Sales well up for the quarter as Exactech sees overall sales revenue growth for the quarter of 13% year on year.
Medtronic To Cut Further $1.2 Billion In 5 Years
Medtronic CFO Gary Ellis’s statement of intent to further reduce cost base.
Winners And Losers From Q2 Orthopaedic Financials
Orthopaedic Companies’ financial results from Q2 in one summary table
Optos Retinal Imaging Company Sales Up 35%, Operating Profit Up 43%
Optos plc (LSE: OPTS), a leading medical retinal imaging company, has announced strong preliminary results for the year ended 30 September 2011.
Medtronic Reports Q2 Sales Growth
Medtronic Inc.has reported higher-than-expected second quarter earnings as sales of newer devices helped make up for an ongoing slump in its best-selling heart and spine implants.
Despite Higher Sales, Atricure 3rd Quarter Loss Increased as Margins Decrease and Operational Costs Climb
Atricure’s Quarterly Earnings Report gives reason for optimism despite increased losses.
Smith and Nephew Quarterly Results: Efficiency Improvements in Orthopaedics Group are Key
Smith & Nephew results for the third quarter show revenue increase, margin decrease and $150m cost reduction plans.
St. Jude 3rd quarter earnings call: Medtronic sparks Starks criticism
St Jude CEO Daniel Starks blasted rival Medtronic in 3rd quarter earnings call.
Arthrocare First Quarter Revenue Growth
Arthrocare are back in the game with a strong first quarter for 2010.
Stryker CEO: Sales growth slows, for now…
Stryker Corp. won’t achieve a ninth straight year of double-digit sales growth this year, the company’s chief executive officer told Stryker shareholders Wednesday.
Sales fall in Smith & Nephew’s orthopeadics division
Citing weak global markets, Smith & Nephew PLC reported a 5 percent decline in revenues for the first quarter of 2009, falling from $911 million in the year-ago quarter to $865 million.
Angiotech Pharmaceuticals, Inc. Announces Financial Results For The Fourth Quarter Ended December 31, 2008
Angiotech Pharmaceuticals, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2008.
Following a period of yielding results and unpleasant decisions, things are now moving in the right direction for Coloplast.
In the first quarter, Coloplast achieved an organic growth rate of 6% and an operating profit margin of 15%. If exchange rates had not been unfavourable to Coloplast, the operating profit margin would have been 17% against 16% for the same period last year.